HEPATIC IMPAIRMENT (HI)
Clinical trials for HEPATIC IMPAIRMENT (HI) explained in plain language.
Never miss a new study
Get alerted when new HEPATIC IMPAIRMENT (HI) trials appear
Sign up with your email to follow new studies for HEPATIC IMPAIRMENT (HI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Drug's journey through the body tested in liver health study
Knowledge-focused Recruiting nowThis early-stage study looks at how a single dose of the experimental drug EDG-7500 stays in the blood of people with mild or moderate liver problems compared to those with healthy livers. About 32 adults will take one pill, and researchers will measure drug levels and check for …
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase: PHASE1 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 05:54 UTC
-
Liver function and drug processing: a new study
Knowledge-focused Recruiting nowThis study looks at how the drug nemtabrutinib is processed in the body of people with moderate liver impairment compared to healthy individuals. About 32 adults will take a single dose of the drug, and researchers will measure drug levels and safety. The goal is to understand if…
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC